Contract Research Organisation (CRO) Services Market Size, Share, Growth And Forecast 2026-2035 Outsourcing Drives 7.00% CAGR As Market Reaches USD 108.31 Billion
Dublin, Oct. 06, 2026 (GLOBE NEWSWIRE) -- "Contract Research Organisation (CRO) Services Market Size - Share Outlook, Growth Analysis Report and Forecast Trends (2026-2035)" has been added to ResearchAndMarkets.com's offering.
Global Contract Research Organisation (CRO) Services Market to Reach USD 108.31 Billion by 2035
The global contract research organisation (CRO) services market was valued at USD 55.06 Billion in 2025 and is projected to reach USD 108.31 Billion by 2035, expanding at a CAGR of 7.00% during 2026-2035. Market growth is being supported by increased outsourcing among pharmaceutical, biotechnology, and medical device companies seeking to reduce costs, accelerate development timelines, manage complex studies, and strengthen regulatory compliance.
Key Contract Research Organisation (CRO) Services Market Insights
- The clinical services segment accounted for nearly 75% of the market during the historical period. Oncology is expected to lead the market by therapeutic indication through 2035. Asia Pacific represented approximately 46% of historical revenue and remained the largest regional market in 2025. Rising research and development investment, increasingly complex clinical trials, and demand for integrated service models are creating new growth opportunities.
Market Growth Drivers
Pharmaceutical and biotechnology companies are increasingly outsourcing clinical trials, regulatory consulting, data management, biostatistics, pharmacovigilance, site monitoring, medical writing, and other research activities. This approach provides access to specialized expertise and scalable infrastructure while helping sponsors improve operational efficiency and maintain quality standards throughout the development process.
The growing burden of chronic and life-threatening diseases is also increasing demand for clinical research. According to the Global Initiative for Asthma, asthma affects more than 260 million people and causes over 450,000 deaths annually worldwide. The need for new respiratory treatments is expected to generate additional demand for trial design, patient recruitment, data analysis, safety monitoring, and regulatory support.
Oncology will remain a major source of CRO services market growth. The World Health Organization projects more than 35 million new cancer cases by 2050, a 77% increase from 2022. Expanding oncology pipelines, biomarker-led studies, precision medicine programs, and complex trial protocols are strengthening demand for specialized clinical development capabilities.
Strategic Consolidation and Integrated Services
Mergers, acquisitions, and partnerships are reshaping the competitive environment as CROs expand their geographic coverage and end-to-end service portfolios. In November 2025, P95 and Julius Clinical merged to establish a science-led CRO with more than 500 professionals across 25+ countries. The combined organization integrates clinical trial expertise with real-world evidence capabilities, improving its ability to support complex international studies.
Technology investment is another important contract research organisation services market trend. CROs are adopting AI-driven platforms, advanced analytics, decentralized study tools, and real-time data systems to improve trial execution and decision-making. In September 2025, ACL Digital acquired Symbiance to expand its AI-driven clinical research capabilities, highlighting the growing strategic importance of technology-enabled services.
Market Segmentation
By service type, the market includes drug discovery, preclinical, clinical, data analysis & reporting, clinical data monitoring, project management, consulting services, and others. Clinical services hold the leading share as sponsors outsource increasingly complex study activities across multiple development phases.
By therapeutic indication, the market covers oncology, cardiovascular, central nervous system (CNS), dermatology, respiratory, and other disease areas. Oncology is projected to lead because of high research investment, expanding treatment pipelines, and the specialized requirements associated with cancer trials.
Key end-users include academic & research institutes, biotech companies, medical device companies, and other organizations. Regional coverage comprises North America, Europe, Asia Pacific, Latin America, and Middle East and Africa.
Regional Outlook
Asia Pacific is expected to retain its leading position in the global CRO services market. Its growth is supported by cost-effective clinical trials, large and diverse patient populations, expanding pharmaceutical research, improving healthcare infrastructure, and supportive regulatory frameworks. North America and Europe also remain important markets due to substantial research spending, mature life sciences industries, and strong demand for outsourced development services.
Competitive Landscape
Australian Healthcare Solutions provides medical device clinical trial consultancy, field clinical support, regulatory guidance, and reimbursement assistance. Its capabilities support medtech companies across product development, approval, and commercialization.
Avance Clinical is an Australia-based CRO offering full-service support across early and late-phase clinical development. Its ClinicReady platform and Phase I trial capabilities help biotechnology companies improve regulatory readiness and accelerate study timelines.
Charles River Laboratories delivers preclinical safety assessment, integrated toxicology, IND-enabling studies, pathology, and bioanalytical support. Its advanced platforms and real-time data capabilities assist sponsors with regulatory compliance and therapeutic development.
CMIC HOLDINGS Co., LTD is a Japan-based provider of CRO, site management, and contract development and manufacturing services. Its integrated model supports pharmaceutical and biotechnology companies across clinical development and market entry.
Other prominent participants include George Clinical, HCL Technologies Limited, ICON plc, Medpace Inc., Novotech, Parexel International, SGS SA, and Syneos Health. Competition is expected to intensify as leading CROs pursue partnerships, acquisitions, geographic expansion, and technology investment to address unmet needs and deliver scalable, end-to-end research services.
Key Topics Covered:
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Contract Research Organisation (CRO) Services Market Overview
3.1 Global Contract Research Organisation (CRO) Services Market Historical Value (2019-2025)
3.2 Global Contract Research Organisation (CRO) Services Market Forecast Value (2026-2035)
4 Vendor Positioning Analysis
4.1 Key Vendors
4.2 Prospective Leaders
4.3 Niche Leaders
4.4 Disruptors
5 Global Contract Research Organisation (CRO) Services Market Landscape
5.1 Developers Landscape
5.1.1 Analysis by Year of Establishment
5.1.2 Analysis by Company Size
5.1.3 Analysis by Region
5.2 Product Landscape
5.2.1 Analysis by Service Type
5.2.2 Analysis by End-user
6 Global Contract Research Organisation (CRO) Services Market Dynamics
6.1 Market Drivers and Constraints
6.2 SWOT Analysis
6.2.1 Strengths
6.2.2 Weaknesses
6.2.3 Opportunities
6.2.4 Threats
6.3 PESTEL Analysis
6.3.1 Political
6.3.2 Economic
6.3.3 Social
6.3.4 Technological
6.3.5 Legal
6.3.6 Environment
6.4 Porter's Five Forces Model
6.4.1 Bargaining Power of Suppliers
6.4.2 Bargaining Power of Buyers
6.4.3 Threat of New Entrants
6.4.4 Threat of Substitutes
6.4.5 Degree of Rivalry
6.5 Key Demand Indicators
6.6 Key Price Indicators
6.7 Industry Events, Initiatives, and Trends
6.8 Value Chain Analysis
7 Global Contract Research Organisation (CRO) Services Market Segmentation (2019-2035)
7.1 Market by Service Type
7.1.1 Market Overview
7.1.2 Drug Discovery
7.1.3 Preclinical
7.1.4 Clinical
7.1.5 Data Analysis & Reporting
7.1.6 Clinical Data Monitoring
7.1.7 Project Management
7.1.8 Consulting Services
7.1.9 Others
7.2 Market by Therapeutic Indication
7.2.1 Market Overview
7.2.2 Oncology
7.2.3 Cardiovascular
7.2.4 Central Nervous System (CNS)
7.2.5 Dermatology
7.2.6 Respiratory
7.2.7 Others
7.3 Market by End-user
7.3.1 Market Overview
7.3.2 Academic & Research Institutes
7.3.3 Biotech Companies
7.3.4 Medical Device Companies
7.3.5 Others
7.4 Market by Region
7.4.1 Market Overview
7.4.2 North America
7.4.3 Europe
7.4.4 Asia Pacific
7.4.5 Latin America
7.4.6 Middle East and Africa
8 Regional Contract Research Organisation (CRO) Services Market Analysis (2019-2035)
8.1 Regional Analysis Framework
8.1.1 Market by Service Type
8.1.2 Market by Therapeutic Indication
8.1.3 Market by End-user
8.1.4 Market by Country
8.2 North America
8.2.1 United States of America
8.2.2 Canada
8.3 Europe
8.3.1 United Kingdom
8.3.2 Germany
8.3.3 France
8.3.4 Italy
8.3.5 Others
8.4 Asia Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 ASEAN
8.4.5 Australia
8.4.6 Others
8.5 Latin America
8.5.1 Brazil
8.5.2 Argentina
8.5.3 Mexico
8.5.4 Others
8.6 Middle East and Africa
8.6.1 Saudi Arabia
8.6.2 United Arab Emirates
8.6.3 Nigeria
8.6.4 South Africa
8.6.5 Others
9 Regulatory Framework
9.1 Regulatory Overview
9.2 US FDA
9.3 EU EMA
9.4 INDIA CDSCO
9.5 JAPAN PMDA
9.6 Others
10 Strategic Initiatives
10.1 Analysis by Partnership Instances
10.2 Analysis by Type of Partnership and Collaborations
10.3 Analysis by Joint Ventures
10.4 Analysis by Leading Players
10.5 Analysis by Geography
10.6 Analysis by Merger & Acquisitions
11 Supplier Landscape
11.1 Market Share Analysis, By Region (Top 5 Companies)
11.1.1 Global
11.1.2 North America
11.1.3 Europe
11.1.4 Asia Pacific
11.1.5 Others
11.2 Company Profile Coverage
11.2.1 Financial Analysis
11.2.2 Product Portfolio
11.2.3 Demographic Reach and Achievements
11.2.4 Company News & Development
11.2.5 Certifications
11.3 Companies Profiled
11.3.1 Australian Healthcare Solutions
11.3.2 Avance Clinical
11.3.3 Charles River Laboratories
11.3.4 CMIC HOLDINGS Co., LTD
11.3.5 George Clinical
11.3.6 HCL Technologies Limited
11.3.7 ICON plc
11.3.8 Medpace Inc.
11.3.9 Novotech
11.3.10 Parexel International
11.3.11 SGS SA
11.3.12 Syneos Health
12 Global Contract Research Organisation (CRO) Services Market - Distribution Model (Additional Insight)
12.1 Overview
12.2 Potential Distributors
12.3 Key Parameters for Distribution Partner Assessment
13 Key Opinion Leaders (KOL) Insights (Additional Insight)
Companies Featured
- Australian Healthcare Solutions Avance Clinical Charles River Laboratories CMIC HOLDINGS Co., LTD
For more information about this report visit
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept any
responsibility or liability for the accuracy, content, images, videos,
licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright issues
related to this article, kindly contact the provider above.
Comments
No comment